A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users

NCT01825447 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: Oxycodone + Naltrexone
DRUG: Oxycodone

Sponsor

Pfizer

Collaborators

[object Object]